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Abstract
High-resolution, non-destructive imaging with micro-com-
puted tomography (mCT) enables in situ monitoring of tissue
engineered bone constructs. However, it remains controver-
sial, if the locally imposed X-ray dose affects bone devel-
opment and thus could influence the results. Here, we
developed a model system for mCT monitoring of tissue
engineered bone-like constructs. We examined the in vitro
effects of high-resolution mCT imaging on the cellular level
by using pre-osteoblastic MC3T3-E1 cells embedded into
three-dimensional collagen type I matrices. We found no sig-
nificantly reduced cell survival 2 h after irradiation with a
dose of 1.9 Gy. However, 24 h post-irradiation, cell survival
was significantly decreased by 15% compared to non-irra-
diated samples. The highest dose of 7.6 Gy decreased sur-
vival of the pre-osteoblastic MC3T3-E1 cells by around 40%
at 2 days post-irradiation. No significant increase of alkaline
phosphatase (ALP) activity at 2 days post-irradiation was
found with a dose of 1.9 Gy. However, ALP activity was
significantly decreased after 7 days. Using our model system,
the results indicate that mCT imaging with doses as low as
1.9 Gy, which is required to obtain a reasonable image qual-
ity, can induce irreparable damages on the cellular level.
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Introduction
In vitro engineering of functional tissue constructs has gained
importance in the past decade as the shortage of organs and
tissues for transplantation increased w21x, but also for safety
and efficacy testing of new therapeutics w8, 12, 15x. So far,
quality testing of engineered tissue constructs relied on
destructive techniques including reverse transcription poly-
merase chain reaction to analyze gene expression or histol-
ogy to assess organization and integrity of the tissue. Thus,
monitoring over time and functional optimization in response
to assessed changes in tissue morphology and functionality
was not possible with these techniques. Other methods, such
as magnetic resonance imaging or positron emission tomog-
raphy, do not provide sufficient spatial resolution w10, 17x.
Micro-computed tomography (mCT) was shown to be use-
ful as a non-destructive method in imaging three-dimensional
(3D) bone microarchitecture at resolutions in the order of
10 mm in relatively short acquisition time (5–30 min) and
at low cost w2, 3, 19x. In recent studies, mCT was used to
monitor the development of 3D in vitro engineered bone-like
tissues w4, 13, 14x, cartilage-like tissues w23x or skin-like lay-
ers w20x over time. However, one drawback of obtaining
high-quality mCT images can be the locally deposed radia-
tion dose and its potential effect on cell survival, cell func-
tionality and cell development w11x.
Several studies have examined the effects of ionizing radi-
ation on bone cells in a two-dimensional (2D) environment
at doses up to 8 Gy w5, 6, 9x. Although the proliferation of
MC3T3-E1 pre-osteoblastic cells and osteoblast-like cells
from the rat calvarium was not affected by a radiation dose
of 0.4 Gy, a dose of 4.0 Gy significantly decreased prolif-
eration in all studies, and in some cases significantly altered
alkaline phosphatase (ALP) activity, collagen production and
vascular endothelial growth factor secretion as compared to
non-irradiated control samples. However, irradiation effects
on 3D tissue engineered constructs, which mimic native 3D
tissue and organ structures better than 2D environments w8,
12x, are not fully understood. Specifically, the critical dose,
which can maximally be deposited onto the constructs with-
out inducing cellular damages, is not clear. Because there is
a big difference between a flat layer of cells and a complex
3D tissue w1x, it is important to investigate the irradiation
effect in 3D tissues.
The aim of this study was to assess this maximum dose.
We have developed a model system for mCT monitoring of
3D tissue engineered constructs and to elucidate effects of
the ionizing radiation applied by mCT imaging on the cel-
lular level by using MC3T3-E1 pre-osteoblastic cells embed-
ded in 3D collagen type I matrices mimicking bone-like
tissue w7, 16x. We hypothesized that the locally deposed X-
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ray dose by high-resolution mCT imaging can cause altera-
tions on the cellular level in a dose- and time-dependent
manner. This not only can affect the development of engi-
neered 3D tissue constructs for clinical applications but
also the results of pharmaceutical studies for testing new
therapeutics.
Materials and methods
Dose measurement with thermoluminescent
detectors
The radiation dose occurring with typical settings for mCT
scanning was measured with thermoluminescent detectors
(TLDs) made of lithium fluoride powder embedded in a glass
tube of 12 mm length and 1.4 mm diameter (TLD-700, Hars-
haw/Filtrol, Solon, OH, USA). For mCT measurement, the
TLDs were placed in a cylindrical polymethyl methacrylate
(PMMA) cylinder (inner diameter: 2 mm, outer diameter:
8 mm) to ensure corresponding radiation doses as applied to
the cells embedded into the collagen matrix. The mCT
(mCT40, Scanco Medical AG, Bru¨ttisellen, Switzerland) was
operated at a peak voltage of 50 kV with an integration time
of 100 ms in all possible scanning modes. The three primary
scanning modes provided by the mCT manufacturer were
‘‘standard resolution’’ mode (250 projections/1808, 1024
samples per projection), ‘‘medium resolution’’ mode (500
projections/1808, 1024 samples), and ‘‘high resolution’’
mode (1000 projections/1808, 2048 samples). In each mode,
five different nominal resolutions were available namely 12,
16, 20, 30, and 36 mm for the standard and medium reso-
lution mode, and 6, 8, 10, 15, and 18 mm for the high res-
olution mode. These nominal resolution values correspond
to the settings that can be chosen to run the scans and do
not represent the actual spatial resolution, which is typically
lower. The best spatial resolution (10% MTF) at 6 mm voxel
size is specified by the manufacturer to be 10 mm. After
irradiation, the TLDs were read out with a photo-multiplier
using a standard heating protocol.
For all cell experiments the medium resolution mode at
20 mm nominal resolution was used, but with a threefold
increased integration time resulting in a calculated base dose
of 1.9 Gy per measurement. To achieve the higher doses of
3.8, 5.7, and 7.6 Gy, the base measurement was repeated 2,
3, and 4 times, respectively. The total times for application
of these radiation doses were 1.5 h, 3 h, 4.5 h, and 6 h,
respectively. To examine potential differences in image qual-
ity, a bovine trabecular bone sample was scanned with mCT
in four different modes: in standard resolution mode at
30 mm and 16 mm nominal resolution, as well as in high
resolution mode at 15 mm and 8 mm nominal resolution.
Culture of pre-osteoblastic MC3T3-E1 cells
A MC3T3-E1 subclone 24 (LGC Promochem Sarl, Mols-
heim Cedex, France) was cultured between passage 6–10 in
alpha-modified minimum essential medium containing 10%
fetal bovine serum (both Invitrogen, Basel, Switzerland),
1 mg/ml bone morphogenic protein-2 produced as previously
shown w22x, and 25 mmol 4-(2-hydroxyethyl)-1-piperazine-
ethanesulfonic acid (Sigma-Aldrich, Buchs, Switzerland).
Preparation of 3D collagen matrices
Collagen type I matrices (Vitrogen 100, Cohesion, Palo Alto,
CA, USA) of 2 mg/ml were used. Matrix formation was
initiated by raising the pH to physiological conditions (pH
7.4) by adding 0.1 M NaOH to the collagen solution. To
ensure homogeneous cell encapsulation, the matrices were
presolidified at 378C for 5 min prior to the addition of
500,000 cells/ml collagen I. Matrices with a volume of 30 ml
were then filled into sterilized (70% ethanol, exposure to UV
light) PMMA sample holders with a capacity of 35 ml and
incubated for 30 min at 378C to solidify. The sample holders
containing the 3D cell cultures were then kept in 1 ml medi-
um in a well of a 24-well plate under standard cell culture
conditions.
Irradiation with mCT
A high-resolution micro-computed tomography system
(mCT40, Scanco Medical AG, Bru¨ttisellen, Switzerland) was
used to apply the ionizing radiation to the cells embedded in
the 3D collagen type I matrices. The system was operated in
all cell experiments at a peak voltage of 50 kV with an inte-
gration time of 300 ms at a nominal resolution of 20 mm.
The absolute dose delivered to the samples was assessed in
an independent experiment using TLDs. In all experiments,
cultured MC3T3-E1 cells embedded in 3D collagen type I
matrices were exposed to radiation 24 h after seeding into
the collagen matrix. For cell survival experiments, cells were
irradiated with doses of 1.9, 3.8, 5.7, and 7.6 Gy. For DNA
and ALP assays, a dose of 1.9 Gy was applied. Control sam-
ples were placed inside the mCT, shielded with a lead cyl-
inder against potential irradiation. Temperature effects on cell
survival and ALP expression during a mCT run can thus be
excluded. Survival experiments as well as ALP/DNA exper-
iments were all compared with this mCT control.
Cell survival after mCT irradiation
Cell survival after mCT irradiation was determined with a
live/dead cytotoxicity kit (Molecular Probes, Eugene, OR,
USA). This assay was performed 2 h and 24 h post-irradi-
ation (per dose, and per time point: nsamples 3, ncontrols9).
The samples were washed in phosphate buffered saline (PBS,
Sigma Aldrich, Basel, Switzerland) and stained for 45 min
with 200 ml live/dead staining solution (4 mM ethidium
homodimer-1, 2 mM calceinAM in PBS). The samples were
then washed in PBS and fixed in 4% glutaraldehyde. Epi-
fluorescence images were taken at five randomly selected
locations (area of ;2=1 mm2) within the matrix by using
a fluorescence microscope (Zeiss Axiovert 135, Feldbach,
Switzerland) and the fluorescence for calceinAM was deter-
mined with an excitation wavelength of 495 nm and an emis-
sion wavelength of 515 nm. For ethidium homodimer-1, an
excitation wavelength of 495 nm and an emission wave-
T.P. Kraehenbuehl et al.: mCT radiation on tissue engineered bone-like constructs 247
Article in press - uncorrected proof
length of 635 nm were used, respectively. The number of
surviving cells per total number of cells (live cells plus dead
cells, between 30 and 100 cells in total, per location) was
determined by manual counting. The cell numbers of the
irradiated samples were normalized to the non-irradiated
control samples, which were placed into the mCT with lead
shielding.
ALP activity assay
Each sample was homogenized in 300 ml lysis solution
(0.2% v/v Triton X-100 in 0.56 M 2-amino-methyl-1-propa-
nol, pH 10.0). Total number of samples/controls per time
point: nsamples 10, ncontrols10. From each sample an aliquot
was used to determine ALP activity. Briefly, 150 ml of the
lysed cell suspension was mixed with 20 ml of p-nitrophenyl
phosphate solution (74 mg/ml in 0.56 M 2-amino-methyl-1-
propanol, pH 10.0) and incubated at 378C for 30 min. The
reaction was stopped by addition of 85 ml 2 N NaOH. The
ALP activity was then determined by measuring the absor-
bance at 405 nm with a spectrometer (Spectronic Genesys
2PC, Thermo Fisher Scientific, Milford, MA, USA).
DNA determination assay
To determine the DNA content per gel, 30 ml of the lysed
cell suspension was neutralized by addition of 270 ml TE
buffer (100 mM Tris-HCl, pH 7.6, 1 mM EDTA) and centri-
fuged for 15 min at 11,000=g. Then, 270 ml of sample or
DNA standard was mixed with 270 ml Pico Green (Molec-
ular Probes, Eugene, OR, USA) which was diluted 1:200 in
TE buffer. Total number of samples/controls per time point:
nsamples 10, ncontrols10. Fluorescence was measured in trip-
licate using a spectrometer (Synergy HT, BioTek Instru-
ments, Inc., Winooski, VT, USA) at 520 nm (excitation
wavelength: 480 nm).
Statistical analysis
The cell survival experiments were performed at different
doses and are shown as mean values"standard deviation
(total number of samples: per dose and per time point:
nsamples 3, ncontrols9). Each sample point was normalized
by its corresponding control sample. Comparative analysis
was performed with a two-way analysis of variance. To test
for significant differences between the dose groups, a pair-
wise t-test was applied with Holm correction for multiple
testing, for both the 2 h and 24 h time groups. To examine
significant differences between the 2 h and 24 h time groups
within a dose group, we used the Student t-test. Significant
differences were accepted for p-0.05.
The results of the DNA and ALP tests were statistically
analyzed using a pairwise Wilcoxon rank sum test with Holm
correction for multiple testing. Total number of samples/con-
trols per time point: nsamples 10, ncontrols10. Differences
between two data sets were considered statistically signifi-
cant if p-0.05. For all statistical analyses we used ‘‘R’’, a
language and environment for statistical computing (R Foun-
dation for Statistical Computing, Vienna, Austria).
Results
Dose measurement and image quality
To investigate the relation between applied dose and image
quality, a bovine trabecular bone sample was scanned with
mCT applying the doses 0.150 Gy and 0.528 Gy in the stan-
dard resolution mode, and 0.458 Gy and 1.980 Gy in the
high resolution mode (Figure 1A–C). Better image quality
(higher resolution) resulted from higher applied doses (Fig-
ure 1A). The gray level images show a better quality by
increasing the resolution from 30 to 8 mm, and with chang-
ing the imaging mode from standard to high resolution. In
addition, the binary images in high resolution mode were
found to better display the ‘‘real’’ trabecular structure as
compared to the binary images in the standard resolution
mode. However, the differences are relatively small and
depending on the application a low resolution mode can yield
reasonable results at an acceptable dose. We show that the
relation between dose and image quality, here represented as
nominal resolution, can be modeled as a power law with
exponents 1.74, 1.76, and 2.03 for the standard, medium, and
high resolution mode, respectively (Figure 1B,C).
Cell survival after mCT imaging is dose- and
time-dependent
To examine the effects of high-resolution mCT imaging on
a cellular level, we first evaluated the survival rate 2 h and
24 h post-irradiation, with doses of 1.9, 3.8, 5.7, and 7.6 Gy,
respectively, using custom-made PMMA sample holders. We
found no significant increase in cell death for a dose of
1.9 Gy immediately (2 h) after irradiation as compared to
the non-irradiated control group. However, 24 h post-irradi-
ation, cell survival was significantly decreased by 15% over
the control group. Doses after exposure to 3.8 Gy and 5.7 Gy
resulted in survival rates of around 80%. Although we did
not find a significant decrease in cell survival after exposure
to 3.8 Gy between 2 h and 24 h post-irradiation, we dem-
onstrate a significant decrease after exposure to 5.7 Gy by
15%. The highest dose of 7.6 Gy decreased the survival rate
of the cells by around 40% 24 h post-irradiation as compared
to non-irradiated control samples. Nevertheless, no signifi-
cant difference between 2 h and 24 h post-irradiation was
observed for this highest dose.
Time-dependent decrease of ALP activity per cell
To further investigate the cellular effects of high-resolution
mCT imaging, we applied a dose of 1.9 Gy and analyzed
ALP activity. When ALP activity was normalized with the
DNA content of the same sample, we found no significant
increase in ALP activity 2 days post-irradiation, but a sig-
nificant decrease to approximately 60% at 7 days (Figure 2).
Discussion
This is one of the first studies investigating the effect of
ionizing radiation of high-resolution mCT measurements on
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Figure 1 Relation of mCT image quality and applied dose.
(A) mCT images of a bovine trabecular bone sample. Insets show higher magnifications and the corresponding binary images, respectively.
These scans were performed in four different modes: standard resolution at 30 mm and 16 mm nominal resolution (voxel size), and high
resolution at 15 mm and 8 mm nominal resolution. The nominal resolution corresponds to the scanner settings and not to the actual spatial
resolution. (B) The relation between dose and image quality (here given as nominal resolution) can be modeled as a power law with
exponents 1.74, 1.76, and 2.03, for standard, medium and high resolution mode, respectively. (C) Radiation dose in function of the imaging
mode. For all cell experiments the medium resolution mode at 20 mm nominal resolution was used, but with a threefold integration time
resulting in a calculated base dose of 1.9 Gy per measurement. To achieve the higher doses of 3.8, 5.7, and 7.6 Gy, the base measurement
was repeated 2, 3, and 4 times, respectively.
Figure 2 Time-dependent decrease of ALP activity after exposure
to 1.9 Gy radiation dose.
Although no significant alteration in the 2 day post-irradiation group
was found, the ALP activity was significantly decreased by 60% at
7 days post-irradiation. In these box plots, the box represents/con-
tains 50% of the data, and the whiskers show the data range exclud-
ing extreme values that are shown as single data points. Differences
between two data sets were considered statistically significant if
p-0.05 and are indicated in the Figure by a star.
a cellular level by using a 3D tissue-like model system.
Using our model system, the results indicate that mCT imag-
ing with doses as low as 1.9 Gy, which is required to obtain
a reasonable image quality, can induce irreparable damages
on the cellular level.
The dose applied by a mCT measurement depends on the
imaging mode and scanner settings, which are adapted to the
features of interest. For instance, if bone volume density is
of interest, a relatively low image quality could provide suf-
ficiently good results. However, to capture alterations on the
bone surface, a relatively good image quality with high res-
olution is required, which could be needed to expose the
tissue to doses of 2 Gy or even higher. In such cases, the
applied dose is not negligible and could result in potential
side effects on the cellular level as demonstrated in Figures
2 and 3.
Our results indicate that the effects of ionizing radiation
on survival of the pre-osteoblastic MC3T3-E1 cells are dif-
ferent in our 3D model system with collagen type I matrices
mimicking natural bone-like tissue as compared to 2D cul-
ture plates. We show considerably higher survival rates when
similar doses are applied as previously reported for 2D stud-
ies (Figure 3A,B). For instance, it was demonstrated that
osteoblast-like cells from the calvarium of newborn rats sur-
vived only by 60%, 35%, and less than 5% on a 2D surface
when 2, 4, and 6 Gy, respectively, were applied to the culture
w5x. The reason for this difference is unclear. We speculate
that the 3D organization of the cells mimicking a more nat-
ural tissue-like environment than a 2D culture could have a
protective effect, but also supports repair mechanisms more
efficiently after irradiation damage. In addition, shielding
effects of the PMMA sample holder might not be totally
excluded.
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Figure 3 Survival of pre-osteoblastic MC3T3-E1 cells in 3D collagen matrices after mCT imaging.
(A) Representative image of pre-osteoblastic cells in 3D collagen matrices 24 h post-irradiation. (B) Dose- and time-dependent survival 2 h
and 24 h after irradiation as assessed by quantifying live/dead cell staining. At a dose of 2 Gy, which is commonly applied for in vitro and
in vivo imaging, the fraction of surviving cells 24 h after irradiation is significantly lower than at 2 h. The highest dose applied (8 Gy) still
resulted in survival of )60% both at 2 h and 24 h after irradiation. The survival rates at each dose were normalized by the survival rates
of the control samples and are shown as mean values"standard deviation (nsamples 3, ncontrols 9; images were taken at five randomly
selected/representative locations within the matrix). Significant differences were accepted if p-0.05. * Indicates significantly different data
between 2 h and 24 h.
Expression of ALP activity is a relevant marker in the
early differentiation process of MC3T3-E1 pre-osteoblastic
cells towards mature osteoblasts as it is upregulated with
proceeding maturation w18x. We show here a time-dependent
decrease of ALP activity after exposure to radiation (Figure
2). Although no significant alteration was found 2 days post-
irradiation, the ALP activity was significantly decreased at
7 days by around 60%. We speculate that differentiation and
maturation processes could be inhibited after irradiation.
However, it is not clear by which mechanisms the ALP activ-
ity is influenced by irradiation. It could be as a result of
altered cytokine expression profiles, by the irradiation direct-
ly or by combined processes w6x. Other authors found inhi-
bition of differentiation, when exposing mature osteoblasts
in a 2D environment to 4 Gy doses. In a study by Hagen-
mu¨ller et al., ALP activity normalized to the DNA content
was shown to be decreased by around 20% after 3 days of
irradiation, around 60% after 6 days, and around 70% after
9 days. However, a study using 3D scaffolds prepared from
silk fibroin and human mesenchymal stem cells did not dem-
onstrate alterations in ALP activity after repeated high-res-
olution mCT imaging over a period of 28 days w13x. The
reasons for these controversial results on the ALP activity
could include different study designs including different cell
types, radiation doses, the different times between the mCT
imaging and the ALP activity assays, which can allow DNA
repair processes in some cases, as well as the different bio-
physical and biochemical properties of the 3D scaffolds used
in the respective studies.
The direct transfer of the results obtained in this study into
in vivo experiments might not be possible; however, the in
vitro model system applied here allows conclusions for in
vitro tissue engineered constructs or bone chambers (i.e.,
critical dose). The critical dose for in vivo applications needs
to be assessed with the respective in vivo models, specifically
the effects on bone tissue growth, healing, and turnover.
Potential immune reactions, vascularization of the tissue, and
potential shielding effects of the surrounding tissue can affect
the critical dose in vivo.
Conclusion
We have established a model system allowing the monitoring
of 3D tissue engineered constructs using mCT imaging. Our
results indicate significant impairments on the cellular level
after imaging with high-resolution mCT in a time- and dose-
dependent manner. Results from this study indicate that
imaging with high-resolution mCT with doses as low as
1.9 Gy, which is required to obtain a reasonable image qual-
ity, can yield irreparable damages on the cellular level.
It is therefore recommended to use the lowest resolution
necessary in monitoring studies of bone chambers and 3D
tissue engineered bone-like constructs. Future studies could
include other cells such as mesenchymal cells present in
bone tissue and/or different scaffolds, as well as longitudinal
monitoring. Longitudinal animal studies could be performed
to assess a critical in vivo dose to avoid potential damages
on the cellular level.
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